Literature DB >> 22326583

Severe vestibular dysfunction and altered vestibular innervation in mice lacking prosaposin.

Omar Akil1, Lawrence R Lustig.   

Abstract

Prosaposin, a precursor of four glycoprotein activators (saposin A, B, C and D) for lysosomal hydrolases, has previously been shown to be important for normal adult cochlear innervation and the maintenance of normal hearing. In these studies, we now investigate prosaposin in normal vestibular epithelium and the functional impairment of balance caused by prosaposin ablation. In normal mice, prosaposin is localized to all 3 vestibular end-organs (ampullae, saccule, and utricle) and Scarpa's ganglion by RT-PCR, Western blot analysis and immunofluorescence. Ablation of prosaposin function caused severe vestibular dysfunction on a battery of behavioral tasks. Histologically, the KO mice demonstrated an exuberant cellular proliferation below the vestibular hair cells with disruption of the supporting cells. Electron microscopy further demonstrated inclusion bodies and cellular proliferation disturbing the normal neuroepithelial structure of the vestibular end-organs. Lastly, immunofluorescence (neurofilament 200 and synaptophysin) staining suggests that this cellular proliferation corresponds to afferent and efferent neuronal overgrowth. These data suggest that prosaposin plays a role not only in the maintenance of normal hearing but also an important role in the neuronal maturation processes of the vestibular sensory epithelium and the maintenance of normal vestibular system function. Copyright Â
© 2012 Elsevier Ireland Ltd and the Japan Neuroscience Society. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22326583      PMCID: PMC3312039          DOI: 10.1016/j.neures.2012.01.007

Source DB:  PubMed          Journal:  Neurosci Res        ISSN: 0168-0102            Impact factor:   3.304


  28 in total

1.  A novel mutation in the coding region of the prosaposin gene leads to a complete deficiency of prosaposin and saposins, and is associated with a complex sphingolipidosis dominated by lactosylceramide accumulation.

Authors:  H Hulková; M Cervenková; J Ledvinová; M Tochácková; M Hrebícek; H Poupetová; A Befekadu; L Berná; B C Paton; K Harzer; A Böör; F Smíd; M Elleder
Journal:  Hum Mol Genet       Date:  2001-04-15       Impact factor: 6.150

2.  Vestibular evidence for the evolution of aquatic behaviour in early cetaceans.

Authors:  F Spoor; S Bajpai; S T Hussain; K Kumar; J G M Thewissen
Journal:  Nature       Date:  2002-05-09       Impact factor: 49.962

3.  Sulfatide activator protein. Alternative splicing that generates three mRNAs and a newly found mutation responsible for a clinical disease.

Authors:  H Holtschmidt; K Sandhoff; H Y Kwon; K Harzer; T Nakano; K Suzuki
Journal:  J Biol Chem       Date:  1991-04-25       Impact factor: 5.157

Review 4.  Motion and vision: why animals move their eyes.

Authors:  M F Land
Journal:  J Comp Physiol A       Date:  1999-10       Impact factor: 1.836

5.  Sodium arsanilate-induced vestibular dysfunction in rats: effects on open-field behavior and spontaneous activity in the automated digiscan monitoring system.

Authors:  K P Ossenkopp; A Prkacin; E L Hargreaves
Journal:  Pharmacol Biochem Behav       Date:  1990-08       Impact factor: 3.533

6.  Prosaposin: threshold rescue and analysis of the "neuritogenic" region in transgenic mice.

Authors:  Ying Sun; Xiaoyang Qi; David P Witte; Elvira Ponce; Keiji Kondoh; Brian Quinn; Gregory A Grabowski
Journal:  Mol Genet Metab       Date:  2002-08       Impact factor: 4.797

7.  Abnormal motor behavior and vestibular dysfunction in the stargazer mouse mutant.

Authors:  Z Khan; J Carey; H J Park; M Lehar; D Lasker; H A Jinnah
Journal:  Neuroscience       Date:  2004       Impact factor: 3.590

8.  Lack of Bdnf and TrkB signalling in the postnatal cochlea leads to a spatial reshaping of innervation along the tonotopic axis and hearing loss.

Authors:  Thomas Schimmang; Justin Tan; Marcus Müller; Ulrike Zimmermann; Karin Rohbock; Iris Kôpschall; Annette Limberger; Liliana Minichiello; Marlies Knipper
Journal:  Development       Date:  2003-10       Impact factor: 6.868

9.  Intratympanic injection of sodium arsanilate (atoxyl) solution results in postural changes consistent with changes described for labyrinthectomized rats.

Authors:  M A Hunt; S W Miller; H C Nielson; K M Horn
Journal:  Behav Neurosci       Date:  1987-06       Impact factor: 1.912

10.  Neurons expressing the highest levels of gamma-synuclein are unaffected by targeted inactivation of the gene.

Authors:  Natalia Ninkina; Katerina Papachroni; Darren C Robertson; Oliver Schmidt; Liz Delaney; Francis O'Neill; Felipe Court; Arnon Rosenthal; Susan M Fleetwood-Walker; Alun M Davies; Vladimir L Buchman
Journal:  Mol Cell Biol       Date:  2003-11       Impact factor: 4.272

View more
  4 in total

1.  Phenotype Expansion for Atypical Gaucher Disease Due to Homozygous Missense PSAP Variant in a Large Consanguineous Pakistani Family.

Authors:  Khurram Liaqat; Shabir Hussain; Anushree Acharya; Abdul Nasir; Thashi Bharadwaj; Muhammad Ansar; Sulman Basit; Isabelle Schrauwen; Wasim Ahmad; Suzanne M Leal
Journal:  Genes (Basel)       Date:  2022-04-09       Impact factor: 4.141

2.  Disrupted bone remodeling leads to cochlear overgrowth and hearing loss in a mouse model of fibrous dysplasia.

Authors:  Omar Akil; Faith Hall-Glenn; Jolie Chang; Alfred Li; Wenhan Chang; Lawrence R Lustig; Tamara Alliston; Edward C Hsiao
Journal:  PLoS One       Date:  2014-05-01       Impact factor: 3.240

3.  Time-Course Evaluation of Iminodipropionitrile-Induced Liver and Kidney Toxicities in Rats: A Biochemical, Molecular and Histopathological Study.

Authors:  Manar A Alwelaie; Mohsen G Al-Mutary; Nikhat J Siddiqi; Maha M Arafah; Abdullah S Alhomida; Haseeb A Khan
Journal:  Dose Response       Date:  2019-05-23       Impact factor: 2.658

Review 4.  Progress in protecting vestibular hair cells.

Authors:  Luoying Jiang; Zhiwei Zheng; Yingzi He
Journal:  Arch Toxicol       Date:  2021-05-13       Impact factor: 5.153

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.